Target intelligence / Profile preview

Protein-RNA interaction interface (not a specific molecule, generic structural term)

Molecular classification
Other (interface region rather than a well-defined molecular class), Interfaces typically arise in ribonucleoprotein particles, RNA-binding proteins, and multi-molecular complexes
01

Overview

Protein-RNA interaction interfaces are regions where proteins and RNA molecules directly associate through non-covalent interactions (hydrogen bonding, van der Waals contacts, and electrostatic forces), often involving conserved amino acid and nucleotide contacts. These interfaces are essential for the function of ribonucleoprotein complexes, control gene expression, RNA splicing, translation, and many other key cellular processes[1][2][3][4][5][7][8]. Their complexity is underscored by the diversity of RNA-binding proteins, many of which utilize conventional RNA-binding domains (like RNA recognition motifs, K-homology domains, DEAD box helicases) and intrinsically disordered regions to achieve specificity and regulatory control[2][4]. Disruption or aberrant formation of such interfaces is linked to various diseases, highlighting their biological importance but also making them challenging targets for drugs due to the transient and dynamic nature of the interface itself[8]. Current research emphasizes computational approaches to predict and characterize interface features, aiming to facilitate targeted drug discovery and elucidate disease mechanisms[1][6][7].

Other names
RNA-protein interfaceprotein–RNA contact regionprotein–RNA binding surface
02

Mechanism of action

Not applicable to the interface as such; mechanisms may include inhibition or modulation of protein-RNA binding if a drug targets the associated protein

03

Biological functions

Regulation of gene expressionProtein synthesis (e.g., in ribosomes)RNA processingRNA transportSignal transduction (depending on the associated complex)Cell cycle regulation
04

Disease associations

CancerNeurodegenerative disease (e.g., Alzheimer’s)Cardiovascular diseaseOther complex diseases linked to aberrant protein-RNA interactions
05

Safety considerations

Not applicable to the interface per se. Challenges exist in specifically disrupting protein-RNA interfaces without affecting essential cellular processes, leading to potential off-target effects or toxicity
06

Interacting drugs

None specific to the interface as a physical entity. Drug discovery efforts may target proteins at these interfaces (e.g., RNA-binding proteins), but not the interface itself
07

Biomarkers

None established for the interface alone. Biomarkers are generally proteins or RNA species involved in complex formation, not the interface directly

Beyond the preview

Go deeper on Protein-RNA interaction interface (not a specific molecule, generic structural term).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Protein-RNA interaction interface (not a specific molecule, generic structural term).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call